Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading

International Journal of Cancer

Volumn 93, Issue 6, 2001, Pages 841-847

  Lally, Kate M ^a   Mocellin, Simone ^a   Ohnmacht, Galen A ^a   Nielsen, Mai Britt ^a   Bettinotti, Maria ^a   Panelli, Monica C ^a   Monsurro, Vladia ^a   Marincola, Francesco M ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epitope spreading; Immunotherapy; MAGE; Tumor antigens; Vaccines

Indexed keywords

EPITOPE; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOTHERAPY; MELANOMA; METASTASIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ALLELES; ANTIGENS, NEOPLASM; EPITOPES; GENES, MHC CLASS I; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MELANOMA; NEOPLASM PROTEINS; PEPTIDES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0035885252     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1420     Document Type: Article

References (31)

1. Cancer vaccines based on the identification of genes encoding cancer regression antigens
2. Is cancer dangerous to the immune system?
3. Escape of human solid tumors from T cell recognition: Molecular mechanisms and functional significance
4. Immune surveillance against a solid tumor fails because of immunological ignorance
5. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
6. Functional dissociation between local and systemic immune response following peptide vaccination
7. Identification of a tumor infiltrating lymphocyte recognizing MAGE-12 in a melanoma metastasis with decreased expression of melanoma differentiation antigens
8. Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy
9. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
10. An innate sense of danger
11. Immunodominance across the HLA polymorphism: Implications for cancer immunotherapy
12. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)
13. Structure, chromosomal localization and expression of 12 genes of the MAGE family
14. 8+ T cells with enhanced functional characteristics: Implications for more effective immunotherapy
15. MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant epitope
16. Selective human leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells
17. Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model
18. Improved induction of melanoma reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201 binding residues
19. Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T-lymphocytes
20. Induction of tumor reactive CTL from peripheral blood and tumor infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1
21. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition
22. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens
23. Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines
24. Conservation versus polymorphism of the MHC in relation to transplantation, immune responses and autoimmune disease
25. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: Evidence for in vivo priming by tumor cells
26. 2+ melanoma patients have a memory phenotype
27. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
28. Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides
29. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis
30. Short-term kinetics of tumor antigen expression in response to vaccination
31. Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12